Dasatinib Monohydrate

别名: BMS-354825 Monohydrate 中文名称:达沙替尼一水合物

Dasatinib Monohydrate (BMS-354825)是一种新型有效的多靶点抑制剂,作用于靶点AblSrc 和 c-Kit,IC50分别为 <1 nM,0.8 nM 和 79 nM。

Dasatinib Monohydrate Chemical Structure

Dasatinib Monohydrate Chemical Structure

CAS: 863127-77-9

规格 价格 库存 购买数量
50mg RMB 811.64 现货
200mg RMB 1610.04 现货
更大包装 有超大折扣

400-668-6834

info@selleck.cn

免费分装
免费预溶

客户使用Selleck的Dasatinib Monohydrate发表文献236

产品质控

批次: 纯度: 99.62%
99.00

Dasatinib Monohydrate相关产品

相关信号通路图

Src抑制剂选择性比较

细胞实验数据示例

细胞系 实验类型 给药浓度 孵育时间 活性描述 文献信息
K562 cell Proliferation assay 72 h Antiproliferative activity against human K562 cells after 72 hrs, IC50=0.001 μM 15615512
WiDr cell Proliferation assay 72 h Antiproliferative activity against human WiDr cells after 72 hrs, IC50=0.052 μM 15615512
PC3 cell Proliferation assay 72 h Antiproliferative activity against human PC3 cells after 72 hrs, IC50=0.0094 μM 15615512
MDA-MB-231 cell Proliferation assay 72 h Antiproliferative activity against human MDA-MB-231 cells after 72 hrs, IC50=0.012 μM 15615512
M07ep210 cell Growth inhibition assay 48 h Growth inhibition of human M07ep210 cells after 48 hrs by [3H]thymidine uptake assay, IC50=0.07 nM 17956080
K562 cell Growth inhibition assay 48 h Growth inhibition of human K562 cells after 48 hrs by [3H]thymidine uptake assay, IC50=0.001 μM 17956080
M07e cell Growth inhibition assay 48 h Growth inhibition of human M07e cells after 48 hrs by [3H]thymidine uptake assay, IC50=0.0012 μM 17956080
K562 cell Cytotoxicity assay 72 h Cytotoxicity against human K562 cells after 72 hrs by WST-8 reagent based MTT assay, IC50=12.83 μM 22217877
U937 cell Cytotoxicity assay 72 h Cytotoxicity against human U937 cells after 72 hrs by WST-8 reagent based MTT assay, IC50=13.63 μM 22217877
K562 cell Proliferation assay 72 h Antiproliferative activity against human K562 cells after 72 hrs by CCK8 assay, IC50=0.7 nM 23521020
MDA-MB-435S cell Proliferation assay 72 h Antiproliferative activity against human MDA-MB-435S cells after 72 hrs by MTT assay, IC50=3.9 μM 23521020
NCI-H460 cell Proliferation assay 72 h Antiproliferative activity against human NCI-H460 cells after 72 hrs by MTT assay, IC50=8.99 μM 23521020
NCI-H23 cell Proliferation assay 72 h Antiproliferative activity against human NCI-H23 cells after 72 hrs by MTT assay, IC50=2.27 μM 23521020
A549 cell Proliferation assay 72 h Antiproliferative activity against human A549 cells after 72 hrs by MTT assay, IC50=12.66 μM 23521020
T47D cell Proliferation assay 72 h Antiproliferative activity against human T47D cells after 72 hrs by MTT assay, IC50=0.9 μM 23521020
HCT116 cell Proliferation assay 72 h Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay, IC50=2.3 μM 23521020
MCF7 cells Proliferation assay 72 h Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay, IC50=2.57 μM 23521020
RXF 393NL cell Cytotoxicity assay 4 days Cytotoxicity against human RXF 393NL cells after 4 days by propidium iodide staining, IC50=21.7 nM 23253074
PRXF DU145 cell Cytotoxicity assay 4 days Cytotoxicity against human PRXF DU145 cells after 4 days by propidium iodide staining, IC50=0.0623 μM 23253074
LXFA 983L cell Cytotoxicity assay 4 days Cytotoxicity against human LXFA 983L cells after 4 days by propidium iodide staining, IC50=56.5 nM 23253074
GXF251L cell Cytotoxicity assay 4 days Cytotoxicity against human GXF251L cells after 4 days by propidium iodide staining, IC50=2.25 μM 23253074
CXF 1103L cell Cytotoxicity assay 4 days Cytotoxicity against human CXF 1103L cells after 4 days by propidium iodide staining, IC50=4.36 μM 23253074
PAXF 1657L cell Cytotoxicity assay 4 days Cytotoxicity against human PAXF 1657L cells after 4 days by propidium iodide staining, IC50=0.121 μM 23253074
NCI-H1648 cell Growth inhibition assay Inhibition of human NCI-H1648 cell growth in a cell viability assay, IC50=0.02011 μM SANGER
NCI-H1838 cell Growth inhibition assay Inhibition of human NCI-H1838 cell growth in a cell viability assay, IC50=1.30733 μM SANGER
NCI-H2126 cell Growth inhibition assay Inhibition of human NCI-H2126 cell growth in a cell viability assay, IC50=2.87552 μM SANGER
NCI-H2141 cell Growth inhibition assay Inhibition of human NCI-H2141 cell growth in a cell viability assay, IC50=24.7754 μM SANGER
NCI-H2107 cell Growth inhibition assay Inhibition of human NCI-H2107 cell growth in a cell viability assay, IC50=43.4847 μM SANGER
NCI-H747 cell Growth inhibition assay Inhibition of human NCI-H747 cell growth in a cell viability assay, IC50=0.08362 μM SANGER
NCI-H720 cell Growth inhibition assay Inhibition of human NCI-H720 cell growth in a cell viability assay, IC50=20.2733 μM SANGER
NKM-1 cell Growth inhibition assay Inhibition of human NKM-1 cell growth in a cell viability assay.IC50=1.30859 μM SANGER
NMC-G1 cell Growth inhibition assay Inhibition of human NMC-G1 cell growth in a cell viability assay.IC50=0.11606 μM SANGER
NTERA-S-cl-D1 cell Growth inhibition assay Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay.IC50=0.12283 μM SANGER
OCI-AML2 cell Growth inhibition assay Inhibition of human OCI-AML2 cell growth in a cell viability assay.IC50=5.86154 μM SANGER
OCUB-M cell Growth inhibition assay Inhibition of human OCUB-M cell growth in a cell viability assay.IC50=1.04412 μM SANGER
OPM-2 cell Growth inhibition assay Inhibition of human OPM-2 cell growth in a cell viability assay.IC50=4.27685 μM SANGER
OS-RC-2 cell Growth inhibition assay Inhibition of human OS-RC-2 cell growth in a cell viability assay.IC50=0.0203 μM SANGER
ONS-76 cell Growth inhibition assay Inhibition of human ONS-76 cell growth in a cell viability assay.IC50=0.42951 μM SANGER
OVCAR-4 cell Growth inhibition assay Inhibition of human OVCAR-4 cell growth in a cell viability assay.IC50=0.37433 μM SANGER
NCI-H446 cell Growth inhibition assay Inhibition of human NCI-H446 cell growth in a cell viability assay.IC50=0.6276 μM SANGER
NCI-H510A cell Growth inhibition assay Inhibition of human NCI-H510A cell growth in a cell viability assay.IC50=19.3973 μM SANGER
PF-382 cell Growth inhibition assay Inhibition of human PF-382 cell growth in a cell viability assay.IC50=0.17678 μM SANGER
NCI-H64 cell Growth inhibition assay Inhibition of human NCI-H64 cell growth in a cell viability assay.IC50=29.6253 μM SANGER
PSN1 cell Growth inhibition assay Inhibition of human PSN1 cell growth in a cell viability assay.IC50=0.04474 μM SANGER
QIMR-WIL cell Growth inhibition assay Inhibition of human QIMR-WIL cell growth in a cell viability assay.IC50=0.70629 μM SANGER
RL95-2 cell Growth inhibition assay Inhibition of human RL95-2 cell growth in a cell viability assay.IC50=0.1038 μM SANGER
RCC10RGB cell Growth inhibition assay Inhibition of human RCC10RGB cell growth in a cell viability assay.IC50=0.4911 μM SANGER
RKO cell Growth inhibition assay Inhibition of human RKO cell growth in a cell viability assay.IC50=0.52966 μM SANGER
NCI-SNU-16 cell Growth inhibition assay Inhibition of human NCI-SNU-16 cell growth in a cell viability assay.IC50=8.56128 μM SANGER
RPMI-6666 cell Growth inhibition assay Inhibition of human RPMI-6666 cell growth in a cell viability assay.IC50=7.27067 μM SANGER
NEC8 cell Growth inhibition assay Inhibition of human NEC8 cell growth in a cell viability assay.IC50=44.336 μM SANGER
RS4-11 cell Growth inhibition assay Inhibition of human RS4-11 cell growth in a cell viability assay.IC50=7.65787 μM SANGER
RXF393 cell Growth inhibition assay Inhibition of human RXF393 cell growth in a cell viability assay.IC50=0.02357 μM SANGER
Raji cell Growth inhibition assay Inhibition of human Raji cell growth in a cell viability assay.IC50=13.7497 μM SANGER
NOS-1 cell Growth inhibition assay Inhibition of human NOS-1 cell growth in a cell viability assay.IC50=0.006129 μM SANGER
SBC-1 cell Growth inhibition assay Inhibition of human SBC-1 cell growth in a cell viability assay.IC50=1.57984 μM SANGER
SF126 cell Growth inhibition assay Inhibition of human SF126 cell growth in a cell viability assay.IC50=0.3541 μM SANGER
SF539 cell Growth inhibition assay Inhibition of human SF539 cell growth in a cell viability assay.IC50=13.8557 μM SANGER
SH-4 cell Growth inhibition assay Inhibition of human SH-4 cell growth in a cell viability assay.IC50=0.18413 μM SANGER
OMC-1 cell Growth inhibition assay Inhibition of human OMC-1 cell growth in a cell viability assay.IC50=27.1422 μM SANGER
SIG-M5 cell Growth inhibition assay Inhibition of human SIG-M5 cell growth in a cell viability assay.IC50=9.02493 μM SANGER
SJSA-1 cell Growth inhibition assay Inhibition of human SJSA-1 cell growth in a cell viability assay.IC50=8.72805 μM SANGER
SK-LMS-1 cell Growth inhibition assay Inhibition of human SK-LMS-1 cell growth in a cell viability assay.IC50=3.11886 μM SANGER
SK-NEP-1 cell Growth inhibition assay Inhibition of human SK-NEP-1 cell growth in a cell viability assay.IC50=8.89155 μM SANGER
SKM-1 cell Growth inhibition assay Inhibition of human SKM-1 cell growth in a cell viability assay.IC50=9.01734 μM SANGER
SK-PN-DW cell Growth inhibition assay Inhibition of human SK-PN-DW cell growth in a cell viability assay.IC50=36.1943 μM SANGER
SK-UT-1 cell Growth inhibition assay Inhibition of human SK-UT-1 cell growth in a cell viability assay.IC50=2.16693 μM SANGER
SNB75 cell Growth inhibition assay Inhibition of human SNB75 cell growth in a cell viability assay.IC50=0.04435 μM SANGER
REH cell Growth inhibition assay Inhibition of human REH cell growth in a cell viability assay.IC50=20.6357 μM SANGER
SNU-C2B cell Growth inhibition assay Inhibition of human SNU-C2B cell growth in a cell viability assay.IC50=1.30589 μM SANGER
RPMI-8866 cell Growth inhibition assay Inhibition of human RPMI-8866 cell growth in a cell viability assay.IC50=17.4455 μM SANGER
SW872 cell Growth inhibition assay Inhibition of human SW872 cell growth in a cell viability assay.IC50=0.04161 μM SANGER
SW962 cell Growth inhibition assay Inhibition of human SW962 cell growth in a cell viability assay.IC50=0.11292 μM SANGER
SF268 cell Growth inhibition assay Inhibition of human SF268 cell growth in a cell viability assay.IC50=0.17404 μM SANGER
TE-1 cell Growth inhibition assay Inhibition of human TE-1 cell growth in a cell viability assay.IC50=0.1054 μM SANGER
8-MG-BA cell Growth inhibition assay Inhibition of human 8-MG-BA cell growth in a cell viability assay.IC50=0.15458 μM SANGER
A101D cell Growth inhibition assay Inhibition of human A101D cell growth in a cell viability assay.IC50=1.03043 μM SANGER
A253 cell Growth inhibition assay Inhibition of human A253 cell growth in a cell viability assay.IC50=3.73246 μM SANGER
A3-KAW cell Growth inhibition assay Inhibition of human A3-KAW cell growth in a cell viability assay.IC50=0.98452 μM SANGER
A4-Fuk cell Growth inhibition assay Inhibition of human A4-Fuk cell growth in a cell viability assay.IC50=38.1009 μM SANGER
A388 cell Growth inhibition assay Inhibition of human A388 cell growth in a cell viability assay.IC50=0.05095 μM SANGER
ACN cell Growth inhibition assay Inhibition of human ACN cell growth in a cell viability assay.IC50=1.82252 μM SANGER
A704 cell Growth inhibition assay Inhibition of human A704 cell growth in a cell viability assay.IC50=0.01491 μM SANGER
ALL-PO cell Growth inhibition assay Inhibition of human ALL-PO cell growth in a cell viability assay.IC50=10.7938 μM SANGER
ARH-77 cell Growth inhibition assay Inhibition of human ARH-77 cell growth in a cell viability assay.IC50=3.46915 μM SANGER
SR cell Growth inhibition assay Inhibition of human SR cell growth in a cell viability assay.IC50=4.49954 μM SANGER
BB65-RCC cell Growth inhibition assay Inhibition of human BB65-RCC cell growth in a cell viability assay.IC50=0.08227 μM SANGER
BB49-HNC cell Growth inhibition assay Inhibition of human BB49-HNC cell growth in a cell viability assay.IC50=0.38599 μM SANGER
BC-1 cell Growth inhibition assay Inhibition of human BC-1 cell growth in a cell viability assay.IC50=28.651 μM SANGER
BC-3 cell Growth inhibition assay Inhibition of human BC-3 cell growth in a cell viability assay.IC50=12.1138 μM SANGER
BL-41 cell Growth inhibition assay Inhibition of human BL-41 cell growth in a cell viability assay.IC50=0.29123 μM SANGER
BL-70 cell Growth inhibition assay Inhibition of human BL-70 cell growth in a cell viability assay.IC50=0.0000008218 μM SANGER
SW684 cell Growth inhibition assay Inhibition of human SW684 cell growth in a cell viability assay.IC50=0.3498 μM SANGER
BOKU cell Growth inhibition assay Inhibition of human BOKU cell growth in a cell viability assay.IC50=0.49133 μM SANGER
SW954 cell Growth inhibition assay Inhibition of human SW954 cell growth in a cell viability assay.IC50=0.02927 μM SANGER
C2BBe1 cell Growth inhibition assay Inhibition of human C2BBe1 cell growth in a cell viability assay.IC50=0.08308 μM SANGER
BV-173 cell Growth inhibition assay Inhibition of human BV-173 cell growth in a cell viability assay.IC50=0.000000109 μM SANGER
Becker cell Growth inhibition assay Inhibition of human Becker cell growth in a cell viability assay.IC50=0.03003 μM SANGER
SW982 cell Growth inhibition assay Inhibition of human SW982 cell growth in a cell viability assay.IC50=0.01115 μM SANGER
697 cell Growth inhibition assay Inhibition of human 697 cell growth in a cell viability assay.IC50=0.19987 μM SANGER
TE-15 cell Growth inhibition assay Inhibition of human TE-15 cell growth in a cell viability assay.IC50=0.005891 μM SANGER
TE-11 cell Growth inhibition assay Inhibition of human TE-11 cell growth in a cell viability assay.IC50=0.07858 μM SANGER
TE-5 cell Growth inhibition assay Inhibition of human TE-5 cell growth in a cell viability assay.IC50=1.79139 μM SANGER
TE-6 cell Growth inhibition assay Inhibition of human TE-6 cell growth in a cell viability assay.IC50=1.21226 μM SANGER
TE-9 cell Growth inhibition assay Inhibition of human TE-9 cell growth in a cell viability assay.IC50=0.87532 μM SANGER
TGBC24TKB cell Growth inhibition assay Inhibition of human TGBC24TKB cell growth in a cell viability assay.IC50=0.04761 μM SANGER
TGW cell Growth inhibition assay Inhibition of human TGW cell growth in a cell viability assay.IC50=11.2828 μM SANGER
TK10 cell Growth inhibition assay Inhibition of human TK10 cell growth in a cell viability assay.IC50=0.01174 μM SANGER
TGBC1TKB cell Growth inhibition assay Inhibition of human TGBC1TKB cell growth in a cell viability assay.IC50=0.06164 μM SANGER
A498 cell Growth inhibition assay Inhibition of human A498 cell growth in a cell viability assay.IC50=0.07284 μM SANGER
UACC-257 cell Growth inhibition assay Inhibition of human UACC-257 cell growth in a cell viability assay.IC50=12.9198 μM SANGER
U-87-MG cell Growth inhibition assay Inhibition of human U-87-MG cell growth in a cell viability assay.IC50=30.766 μM SANGER
BB30-HNC cell Growth inhibition assay Inhibition of human BB30-HNC cell growth in a cell viability assay.IC50=0.05437 μM SANGER
no-10 cell Growth inhibition assay Inhibition of human no-10 cell growth in a cell viability assay.IC50=0.31931 μM SANGER
CAS-1 cell Growth inhibition assay Inhibition of human CAS-1 cell growth in a cell viability assay.IC50=1.40992 μM SANGER
CGTH-W-1 cell Growth inhibition assay Inhibition of human CGTH-W-1 cell growth in a cell viability assay.IC50=0.03548 μM SANGER
TE-10 cell Growth inhibition assay Inhibition of human TE-10 cell growth in a cell viability assay.IC50=0.06357 μM SANGER
COLO-684 cell Growth inhibition assay Inhibition of human COLO-684 cell growth in a cell viability assay.IC50=46.2258 μM SANGER
TE-12 cell Growth inhibition assay Inhibition of human TE-12 cell growth in a cell viability assay.IC50=0.01861 μM SANGER
COR-L279 cell Growth inhibition assay Inhibition of human COR-L279 cell growth in a cell viability assay.IC50=40.2852 μM SANGER
TE-8 cell Growth inhibition assay Inhibition of human TE-8 cell growth in a cell viability assay.IC50=0.01576 μM SANGER
CP66-MEL cell Growth inhibition assay Inhibition of human CP66-MEL cell growth in a cell viability assay.IC50=0.19531 μM SANGER
CTV-1 cell Growth inhibition assay Inhibition of human CTV-1 cell growth in a cell viability assay.IC50=0.00004036 μM SANGER
VA-ES-BJ cell Growth inhibition assay Inhibition of human VA-ES-BJ cell growth in a cell viability assay.IC50=0.03902 μM SANGER
D-263MG cell Growth inhibition assay Inhibition of human D-263MG cell growth in a cell viability assay.IC50=0.36224 μM SANGER
D-336MG cell Growth inhibition assay Inhibition of human D-336MG cell growth in a cell viability assay.IC50=0.006298 μM SANGER
D-502MG cell Growth inhibition assay Inhibition of human D-502MG cell growth in a cell viability assay.IC50=1.23376 μM SANGER
DJM-1 cell Growth inhibition assay Inhibition of human DJM-1 cell growth in a cell viability assay.IC50=6.48558 μM SANGER
no-11 cell Growth inhibition assay Inhibition of human no-11 cell growth in a cell viability assay.IC50=0.50228 μM SANGER
DMS-153 cell Growth inhibition assay Inhibition of human DMS-153 cell growth in a cell viability assay.IC50=14.0028 μM SANGER
DSH1 cell Growth inhibition assay Inhibition of human DSH1 cell growth in a cell viability assay.IC50=0.24001 μM SANGER
DU-4475 cell Growth inhibition assay Inhibition of human DU-4475 cell growth in a cell viability assay.IC50=8.21652 μM SANGER
EB-3 cell Growth inhibition assay Inhibition of human EB-3 cell growth in a cell viability assay.IC50=34.3118 μM SANGER
EHEB cell Growth inhibition assay Inhibition of human EHEB cell growth in a cell viability assay.IC50=10.0656 μM SANGER
COLO-829 cell Growth inhibition assay Inhibition of human COLO-829 cell growth in a cell viability assay.IC50=0.12213 μM SANGER
CP67-MEL cell Growth inhibition assay Inhibition of human CP67-MEL cell growth in a cell viability assay.IC50=0.20488 μM SANGER
ES8 cell Growth inhibition assay Inhibition of human ES8 cell growth in a cell viability assay.IC50=32.1252 μM SANGER
EVSA-T cell Growth inhibition assay Inhibition of human EVSA-T cell growth in a cell viability assay.IC50=9.27793 μM SANGER
ES4 cell Growth inhibition assay Inhibition of human ES4 cell growth in a cell viability assay.IC50=1.05145 μM SANGER
ETK-1 cell Growth inhibition assay Inhibition of human ETK-1 cell growth in a cell viability assay.IC50=0.02832 μM SANGER
ES6 cell Growth inhibition assay Inhibition of human ES6 cell growth in a cell viability assay.IC50=0.03193 μM SANGER
EW-24 cell Growth inhibition assay Inhibition of human EW-24 cell growth in a cell viability assay.IC50=0.78165 μM SANGER
EoL-1-cell cell Growth inhibition assay Inhibition of human EoL-1-cell cell growth in a cell viability assay.IC50=0.00001309 μM SANGER
Calu-6 cell Growth inhibition assay Inhibition of human Calu-6 cell growth in a cell viability assay.IC50=3.05741 μM SANGER
GAK cell Growth inhibition assay Inhibition of human GAK cell growth in a cell viability assay.IC50=31.2686 μM SANGER
D-247MG cell Growth inhibition assay Inhibition of human D-247MG cell growth in a cell viability assay.IC50=6.12519 μM SANGER
GB-1 cell Growth inhibition assay Inhibition of human GB-1 cell growth in a cell viability assay.IC50=0.02157 μM SANGER
GI-ME-N cell Growth inhibition assay Inhibition of human GI-ME-N cell growth in a cell viability assay.IC50=0.06118 μM SANGER
GCIY cell Growth inhibition assay Inhibition of human GCIY cell growth in a cell viability assay.IC50=0.09656 μM SANGER
GT3TKB cell Growth inhibition assay Inhibition of human GT3TKB cell growth in a cell viability assay.IC50=9.35546 μM SANGER
HC-1 cell Growth inhibition assay Inhibition of human HC-1 cell growth in a cell viability assay.IC50=24.5551 μM SANGER
HAL-01 cell Growth inhibition assay Inhibition of human HAL-01 cell growth in a cell viability assay.IC50=19.7543 μM SANGER
HCC1187 cell Growth inhibition assay Inhibition of human HCC1187 cell growth in a cell viability assay.IC50=35.8052 μM SANGER
DEL cell Growth inhibition assay Inhibition of human DEL cell growth in a cell viability assay.IC50=41.9086 μM SANGER
HCC1599 cell Growth inhibition assay Inhibition of human HCC1599 cell growth in a cell viability assay.IC50=32.3325 μM SANGER
DOHH-2 cell Growth inhibition assay Inhibition of human DOHH-2 cell growth in a cell viability assay.IC50=0.01719 μM SANGER
HCC2157 cell Growth inhibition assay Inhibition of human HCC2157 cell growth in a cell viability assay.IC50=37.9946 μM SANGER
HCE-4 cell Growth inhibition assay Inhibition of human HCE-4 cell growth in a cell viability assay.IC50=0.26439 μM SANGER
HCE-T cell Growth inhibition assay Inhibition of human HCE-T cell growth in a cell viability assay.IC50=1.56714 μM SANGER
HEL cell Growth inhibition assay Inhibition of human HEL cell growth in a cell viability assay.IC50=10.4776 μM SANGER
EM-2 cell Growth inhibition assay Inhibition of human EM-2 cell growth in a cell viability assay.IC50=0.000001078 μM SANGER
HT-144 cell Growth inhibition assay Inhibition of human HT-144 cell growth in a cell viability assay.IC50=0.53609 μM SANGER
EW-16 cell Growth inhibition assay Inhibition of human EW-16 cell growth in a cell viability assay.IC50=0.76178 μM SANGER
IA-LM cell Growth inhibition assay Inhibition of human IA-LM cell growth in a cell viability assay.IC50=12.4445 μM SANGER
IST-MEL1 cell Growth inhibition assay Inhibition of human IST-MEL1 cell growth in a cell viability assay.IC50=0.1345 μM SANGER
IST-MES1 cell Growth inhibition assay Inhibition of human IST-MES1 cell growth in a cell viability assay.IC50=0.08552 μM SANGER
GI-1 cell Growth inhibition assay Inhibition of human GI-1 cell growth in a cell viability assay.IC50=1.3622 μM SANGER
IST-SL2 cell Growth inhibition assay Inhibition of human IST-SL2 cell growth in a cell viability assay.IC50=0.50302 μM SANGER
JVM-2 cell Growth inhibition assay Inhibition of human JVM-2 cell growth in a cell viability assay.IC50=2.36284 μM SANGER
JVM-3 cell Growth inhibition assay Inhibition of human JVM-3 cell growth in a cell viability assay.IC50=37.2338 μM SANGER
KALS-1 cell Growth inhibition assay Inhibition of human KALS-1 cell growth in a cell viability assay.IC50=0.0949 μM SANGER
KARPAS-422 cell Growth inhibition assay Inhibition of human KARPAS-422 cell growth in a cell viability assay.IC50=0.33997 μM SANGER
JiyoyeP-2003 cell Growth inhibition assay Inhibition of human JiyoyeP-2003 cell growth in a cell viability assay.IC50=1.73466 μM SANGER
KARPAS-45 cell Growth inhibition assay Inhibition of human KARPAS-45 cell growth in a cell viability assay.IC50=7.51671 μM SANGER
KGN cell Growth inhibition assay Inhibition of human KGN cell growth in a cell viability assay.IC50=0.01942 μM SANGER
KLE cell Growth inhibition assay Inhibition of human KLE cell growth in a cell viability assay.IC50=0.11317 μM SANGER
KNS-42 cell Growth inhibition assay Inhibition of human KNS-42 cell growth in a cell viability assay.IC50=1.24412 μM SANGER
KNS-81-FD cell Growth inhibition assay Inhibition of human KNS-81-FD cell growth in a cell viability assay.IC50=23.146 μM SANGER
KP-N-YS cell Growth inhibition assay Inhibition of human KP-N-YS cell growth in a cell viability assay.IC50=12.9283 μM SANGER
HOP-62 cell Growth inhibition assay Inhibition of human HOP-62 cell growth in a cell viability assay.IC50=0.01834 μM SANGER
KURAMOCHI cell Growth inhibition assay Inhibition of human KURAMOCHI cell growth in a cell viability assay.IC50=0.03487 μM SANGER
HUTU-80 cell Growth inhibition assay Inhibition of human HUTU-80 cell growth in a cell viability assay.IC50=0.3142 μM SANGER
LAMA-84 cell Growth inhibition assay Inhibition of human LAMA-84 cell growth in a cell viability assay.IC50=0.000003207 μM SANGER
LB1047-RCC cell Growth inhibition assay Inhibition of human LB1047-RCC cell growth in a cell viability assay.IC50=0.009887 μM SANGER
LB2518-MEL cell Growth inhibition assay Inhibition of human LB2518-MEL cell growth in a cell viability assay.IC50=0.14162 μM SANGER
LB373-MEL-D cell Growth inhibition assay Inhibition of human LB373-MEL-D cell growth in a cell viability assay.IC50=0.82508 μM SANGER
LB771-HNC cell Growth inhibition assay Inhibition of human LB771-HNC cell growth in a cell viability assay.IC50=2.57551 μM SANGER
LB996-RCC cell Growth inhibition assay Inhibition of human LB996-RCC cell growth in a cell viability assay.IC50=0.009912 μM SANGER
LC-2-ad cell Growth inhibition assay Inhibition of human LC-2-ad cell growth in a cell viability assay.IC50=0.02586 μM SANGER
J-RT3-T3-5 cell Growth inhibition assay Inhibition of human J-RT3-T3-5 cell growth in a cell viability assay.IC50=8.96529 μM SANGER
LP-1 cell Growth inhibition assay Inhibition of human LP-1 cell growth in a cell viability assay.IC50=7.54782 μM SANGER
K-562 cell Growth inhibition assay Inhibition of human K-562 cell growth in a cell viability assay.IC50=0.0000002656 μM SANGER
LS-123 cell Growth inhibition assay Inhibition of human LS-123 cell growth in a cell viability assay.IC50=0.14064 μM SANGER
K5 cell Growth inhibition assay Inhibition of human K5 cell growth in a cell viability assay.IC50=0.16489 μM SANGER
LS-411N cell Growth inhibition assay Inhibition of human LS-411N cell growth in a cell viability assay.IC50=48.4748 μM SANGER
KG-1 cell Growth inhibition assay Inhibition of human KG-1 cell growth in a cell viability assay.IC50=4.60845 μM SANGER
KINGS-1 cell Growth inhibition assay Inhibition of human KINGS-1 cell growth in a cell viability assay.IC50=0.16666 μM SANGER
LXF-289 cell Growth inhibition assay Inhibition of human LXF-289 cell growth in a cell viability assay.IC50=0.03956 μM SANGER
MC116 cell Growth inhibition assay Inhibition of human MC116 cell growth in a cell viability assay.IC50=0.1141 μM SANGER
KS-1 cell Growth inhibition assay Inhibition of human KS-1 cell growth in a cell viability assay.IC50=0.0273 μM SANGER
KU812 cell Growth inhibition assay Inhibition of human KU812 cell growth in a cell viability assay.IC50=0.11883 μM SANGER
MEG-01 cell Growth inhibition assay Inhibition of human MEG-01 cell growth in a cell viability assay.IC50=0.000009805 μM SANGER
MFH-ino cell Growth inhibition assay Inhibition of human MFH-ino cell growth in a cell viability assay.IC50=0.04724 μM SANGER
L-540 cell Growth inhibition assay Inhibition of human L-540 cell growth in a cell viability assay.IC50=15.0671 μM SANGER
MHH-NB-11 cell Growth inhibition assay Inhibition of human MHH-NB-11 cell growth in a cell viability assay.IC50=43.0818 μM SANGER
MMAC-SF cell Growth inhibition assay Inhibition of human MMAC-SF cell growth in a cell viability assay.IC50=8.79307 μM SANGER
LB2241-RCC cell Growth inhibition assay Inhibition of human LB2241-RCC cell growth in a cell viability assay.IC50=9.02012 μM SANGER
LB831-BLC cell Growth inhibition assay Inhibition of human LB831-BLC cell growth in a cell viability assay.IC50=0.04609 μM SANGER
MOLT-16 cell Growth inhibition assay Inhibition of human MOLT-16 cell growth in a cell viability assay.IC50=29.6292 μM SANGER
LC-1F cell Growth inhibition assay Inhibition of human LC-1F cell growth in a cell viability assay.IC50=27.3245 μM SANGER
MOLT-4 cell Growth inhibition assay Inhibition of human MOLT-4 cell growth in a cell viability assay.IC50=26.6753 μM SANGER
MZ1-PC cell Growth inhibition assay Inhibition of human MZ1-PC cell growth in a cell viability assay.IC50=0.03119 μM SANGER
MONO-MAC-6 cell Growth inhibition assay Inhibition of human MONO-MAC-6 cell growth in a cell viability assay.IC50=8.27066 μM SANGER
MZ2-MEL cell Growth inhibition assay Inhibition of human MZ2-MEL cell growth in a cell viability assay.IC50=0.28537 μM SANGER
MPP-89 cell Growth inhibition assay Inhibition of human MPP-89 cell growth in a cell viability assay.IC50=0.04049 μM SANGER
MZ7-mel cell Growth inhibition assay Inhibition of human MZ7-mel cell growth in a cell viability assay.IC50=0.47911 μM SANGER
LOXIMVI cell Growth inhibition assay Inhibition of human LOXIMVI cell growth in a cell viability assay.IC50=0.31503 μM SANGER
NALM-6 cell Growth inhibition assay Inhibition of human NALM-6 cell growth in a cell viability assay.IC50=0.19295 μM SANGER
NB13 cell Growth inhibition assay Inhibition of human NB13 cell growth in a cell viability assay.IC50=19.4877 μM SANGER
NB5 cell Growth inhibition assay Inhibition of human NB5 cell growth in a cell viability assay.IC50=1.39827 μM SANGER
NB17 cell Growth inhibition assay Inhibition of human NB17 cell growth in a cell viability assay.IC50=3.63847 μM SANGER
NCCIT cell Growth inhibition assay Inhibition of human NCCIT cell growth in a cell viability assay.IC50=2.86616 μM SANGER
NB69 cell Growth inhibition assay Inhibition of human NB69 cell growth in a cell viability assay.IC50=0.14436 μM SANGER
NCI-H1304 cell Growth inhibition assay Inhibition of human NCI-H1304 cell growth in a cell viability assay.IC50=28.1628 μM SANGER
NCI-H1395 cell Growth inhibition assay Inhibition of human NCI-H1395 cell growth in a cell viability assay.IC50=42.0163 μM SANGER
MHH-PREB-1 cell Growth inhibition assay Inhibition of human MHH-PREB-1 cell growth in a cell viability assay.IC50=0.74469 μM SANGER
MLMA cell Growth inhibition assay Inhibition of human MLMA cell growth in a cell viability assay.IC50=0.14032 μM SANGER
MN-60 cell Growth inhibition assay Inhibition of human MN-60 cell growth in a cell viability assay.IC50=15.1979 μM SANGER
MV-4-11 cell Growth inhibition assay Inhibition of human MV-4-11 cell growth in a cell viability assay.IC50=4.36454 μM SANGER
NB6 cell Growth inhibition assay Inhibition of human NB6 cell growth in a cell viability assay.IC50=9.92259 μM SANGER
NCI-H1355 cell Growth inhibition assay Inhibition of human NCI-H1355 cell growth in a cell viability assay.IC50=0.11028 μM SANGER
点击查看更多细胞系数据

生物活性

产品描述 Dasatinib Monohydrate (BMS-354825)是一种新型有效的多靶点抑制剂,作用于靶点AblSrc 和 c-Kit,IC50分别为 <1 nM,0.8 nM 和 79 nM。
靶点
Abl [1]
(Cell-free assay)
Src [1]
(Cell-free assay)
c-Kit (D816V) [2]
(Cell-free assay)
c-Kit (wt) [2]
(Cell-free assay)
0.6 nM 0.8 nM 37 nM 79 nM
体外研究(In Vitro)
体外研究活性 Dasatinib比imatinib更有效地抑制表达野生型Bcr-Abl 和Bcr-Abl突变体的Ba/F3细胞的增殖,T315I突变体除外。相对于imatinib,Dasatinib具有双对数(∼325倍)增加的效能。Dasatinib有效抑制野生型Abl激酶和除T315I外小范围的所有突变体。Dasatinib直接靶向作用于所有突变型Abl激酶域,并以浓度依赖的方式抑制自身磷酸化和底物磷酸化。与imatinib相比,Dasatinib对表达野生型Bcr-Abl的细胞表现出325倍的效能。[1] TgE骨髓细胞集落百分数在未处理的孔中为100%,在Dasatinib处理的孔中降低为4.12%。在Dasatinib存在下,WT和TgE骨髓细胞形成的集落百分比在统计学上具有显著差异。LMP2A的表达能够促进B淋巴细胞存活和增殖,这能够被以Lyn 和/或c-Abl激酶为靶点的Dasatinib抑制。[3] Dasatinib治疗抑制一部分甲状腺癌细胞中Src信号,减少生长,并诱导细胞周期阻滞和细胞凋亡。以逐渐增加剂量的纳摩尔级浓度的Dasatinib (0.019 μM到1.25 μM)治疗3天,抑制大约50%的C643,TPC1,BCPAP,和SW1736细胞系生长,而抑制K1细胞系的生长需要更高浓度。10 nM 或50 nM Dasatinib治疗导致BCPAP ,SW1736和 K1细胞中G1期细胞增加9-22%,而S期细胞相应减少7-18%。[4]
激酶实验 激酶自磷酸化测定
激酶试验使用野生型和突变型谷胱甘肽S转移酶(GST)-Abl融合蛋白(c-Abl 氨基酸220-498)进行。GST-Abl在使用前从谷胱甘肽-琼脂糖珠中释放;ATP浓度为5 μM。在用于激酶磷酸化和体外多肽底物磷酸化试验之前,GST-Abl激酶域融合蛋白立即用LAR酪氨酸磷酸酶处理。在30℃下培养1小时后,LAR磷酸酶通过加入钒酸钠(1 mM)灭活。比较未处理的GST-Abl激酶和去磷酸化的GST-Abl激酶,免疫印记分析按照常规进行,使用磷酸酪氨酸特异性抗体4G10以确定酪氨酸残基完全去磷酸化(>95%),使用c-Abl抗体CST 2862确定GST-Abl激酶等量加入。对于突变型T315I,Dasatinib浓度范围扩展到1,000 nM。这些同样的抑制剂浓度用于体外多肽底物磷酸化试验。测试三个抑制剂在相同浓度范围内对GST-Src 激酶和GST-Lyn激酶的抑制作用。
细胞实验 细胞系 Ba/F3 细胞系
浓度 ~32 nM
孵育时间 72小时
方法 Ba/F3细胞系以一式三份接种,并与逐渐增加浓度的Dasatinib培养72小时。使用基于甲烷硫代磺酸盐的活性试验测量增殖。IC50和IC90值以重复四次的三个独立实验平均值确定。抑制剂浓度范围为0 nM到32 nM (Dasatinib)。对于突变型T315I,Dasatinib浓度范围扩展到200 nM。
实验图片 检测方法 检测指标 实验图片 PMID
Western blot phospho-c-Abl(Tyr245) / phospho-c-Src(Tyr416) p27 / p21 cleaved caspase 3 p-FAK/p-STAT3 23049975
Growth inhibition assay Cell viability 23721490
Immunofluorescence SRC / Met α-tubulin F-actin / Actinin-4 / Paxillin 26517812
ELISA TNF-α E-selectin VCAM-1 17684099
体内研究(In Vivo)
体内研究活性 Dasatinib逆转LMP2A/MYC双重转基因小鼠体内的脾肿大。在TgE 小鼠体内,Dasatinib特异性防止LMP2A表达的骨髓B细胞形成集落,并减少脾脏大小。与对照组相比,Dasatinib治疗的Tg6/λ-MYC小鼠中,脾脏肿块显著减小。Dasatinib抑制LMP2A/MYC双重转基因小鼠体内的淋巴结肿大。从LMP2A/MYC双重转基因小鼠移植肿瘤细胞的Rag1KO小鼠体内,Dasatinib逆转脾肿大。Dasatinib治疗抑制表达LMP2A的B淋巴肿瘤细胞中Lyn磷酸化。[3]
动物实验 Animal Models EμLMP2A (TgE和Tg6菌株),MYC (λ-MYC),和LMP2A/λ-MYC 双重转基因小鼠(Tg6/λ-MYC)
Dosages 30 mg/kg
Administration 腹腔注射给药
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05527418 Not yet recruiting
Recent HIV-1 Infection
Eva Bonfill|Institut d''Investigacions Biomèdiques August Pi i Sunyer
November 2023 Phase 2
NCT05993949 Recruiting
Lymphoblastic Leukemia
Stanford University|Kite Pharma
October 2 2023 Phase 1
NCT05780073 Recruiting
HIV Infection Primary
Fundació Institut Germans Trias i Pujol|Fundación FLS de Lucha Contra el Sida Enfermedades Infecciosas y Promoción de la Salud y Ciencia|Spanish Clinical Research Network - SCReN|IrsiCaixa|University of Turin Italy|Instituto de Salud Carlos III|Germans Trias i Pujol Hospital
October 16 2023 Phase 2
NCT05198843 Terminated
Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Triple-Negative Breast Inflammatory Carcinoma
National Cancer Institute (NCI)
November 8 2022 Phase 1|Phase 2
NCT04925648 Recruiting
Metastatic Prostate Cancer
St Vincent''s Hospital Sydney
October 18 2021 Phase 2

化学信息&溶解度

分子量 506.02 分子式

C22H28ClN7O3S

CAS号 863127-77-9 SDF Download Dasatinib Monohydrate SDF
Smiles CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO.O
储存条件(自收到货起)

体外溶解度
批次:

DMSO : 100 mg/mL ( 197.62 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO)

Water : Insoluble

Ethanol : Insoluble

摩尔浓度计算器

体内溶解度
批次:

现配现用,请按从左到右的顺序依次添加,澄清后再加入下一溶剂

动物体内配方计算器

实验计算

摩尔浓度计算器

质量 浓度 体积 分子量

动物体内配方计算器(澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)

mg/kg g μL

第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)

% DMSO % % Tween 80 % ddH2O
%DMSO %

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于μL DMSO溶液(母液浓度mg/mL,:如该浓度超过该批次药物DMSO溶解度,请先联系Selleck);

体内配方配制方法:μL DMSO母液,加入μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入μL ddH2O,混匀澄清。

体内配方配制方法:μL DMSO母液,加入μL Corn oil,混匀澄清。

注意:1. 首先保证母液是澄清的;
2.一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

技术支持

在订购、运输、储存和使用我们的产品的任何阶段,您遇到的任何问题,均可以通过拨打我们的热线电话400-668-6834,或者技术支持邮箱tech@selleck.cn,直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题,请给我们留言。

* 必填项

请输入您的姓名
请输入您的邮箱地址 请输入一个有效的邮箱地址
请写点东西给我们

常见问题及建议解决方法

问题 1:
What’s the difference between S1021 and S7782?

回答:
Usually, hydrate will be more stable and dissolve better than free base. But this compound (S1021) dissolves better in DMSO than hydrate one (S7782).

Tags: buy Dasatinib Monohydrate | Dasatinib Monohydrate supplier | purchase Dasatinib Monohydrate | Dasatinib Monohydrate cost | Dasatinib Monohydrate manufacturer | order Dasatinib Monohydrate | Dasatinib Monohydrate distributor
在线咨询
联系我们